Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Aria F. Olumi, M.D.

Co-Author

This page shows the publications co-authored by Aria Olumi and Mark Preston.
Connection Strength

0.967
  1. 5a-Reductase inhibitors and risk of high-grade or lethal prostate cancer. JAMA Intern Med. 2014 Aug; 174(8):1301-7.
    View in: PubMed
    Score: 0.585
  2. Metformin use and prostate cancer risk. Eur Urol. 2014 Dec; 66(6):1012-20.
    View in: PubMed
    Score: 0.144
  3. Primary spermatic cord tumors: disease characteristics, prognostic factors, and treatment outcomes. Urol Oncol. 2014 Jan; 32(1):52.e19-25.
    View in: PubMed
    Score: 0.139
  4. 5-alpha reductase inhibitors and prostate cancer mortality among men with regular access to screening and health care. Cancer Epidemiol Biomarkers Prev. 2022 Mar 04.
    View in: PubMed
    Score: 0.062
  5. Clinical features of leiomyosarcoma of the urinary bladder: analysis of 183 cases. Urol Oncol. 2014 Oct; 32(7):958-65.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.